Editor: Alfredo G. Torres

Pathogenic Escherichia coli in Latin America

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISBN: 978-1-60805-571-5 (Print)
ISBN: 978-1-60805-192-2 (Online)
Year of Publication: 2010
DOI: 10.2174/97816080519221100101

Introduction

Pathogenic Escherichia coli are known to be a common cause of diarrheal disease – a common cause of frequently occurring bacterial infections in children and adults in developing countries. It poses a significant problem in Latin America. Pathogenic Escherichia coli in Latin America presents current information on understanding pathogenic E. coli in Latin America and outlines prospects for future research in this region. It features a unique, comprehensive analysis of the most common categories of E. coli associated with diarrheal illness in Latin America. The aim of this book is to help epidemiologists in this region to learn about molecular mechanisms of E. coli pathogenesis along with its diagnosis, host immune responses, animal reservoirs and epidemiology. In addition, the authors discuss the current situation of E. coli in representative countries, including Argentina, Brazil, Chile, Mexico and Peru.

Foreword

- Pp. i-ii (2)
Alejandro Cravioto
Download Free

Preface

- Pp. iii
Alfredo G. Torres
Download Free

Contributors

- Pp. iv-vi (3)
Alfredo G. Torres
Download Free

Overview of Escherichia coli

- Pp. 1-7 (7)
Alfredo G Torres, Margarita MP Arenas-Hernandez, Ygnacio Martinez-Laguna
View Abstract

Evolution and Epidemiology of Diarrheagenic Escherichia coli

- Pp. 8-24 (17)
Nina D Williams, Alfredo G Torres, Sonja J Lloyd
View Abstract

Enteropathogenic Escherichia coli (EPEC)

- Pp. 25-47 (23)
Tania AT Gomes, Bertha Gonzalez-Pedrajo
View Abstract

Enteroaggregative Escherichia coli

- Pp. 48-64 (17)
Fernando Navarro-Garcia, Waldir P Elias, Jose Flores, Pablo C Okhuysen
View Abstract

Shiga Toxin-Producing Escherichia coli

- Pp. 65-83 (19)
Beatriz EC Guth, Valeria Prado, Marta Rivas
View Abstract

Enterotoxigenic Escherichia coli

- Pp. 84-94 (11)
Jose Flores, Pablo C. Okhuysen
View Abstract

Detection and Subtyping Methods of Diarrheagenic Escherichia coli Strains

- Pp. 95-115 (21)
Jose Flores, Pablo C. Okhuysen, Elizabeth Miliwebsky, Isabel Chinen, Tania MI Vaz, Kinue Irino
View Abstract

Clinical Management of Escherichia coli Cases (The Latin America Experience)

- Pp. 116-121 (6)
Horacio A Repetto
View Abstract

Host Responses to Pathogenic Escherichia coli

- Pp. 122-141 (20)
Cristina Ibarra, Marina Palermo
View Abstract

Diarrheagenic Escherichia coli in Argentina

- Pp. 142-161 (20)
Marta Rivas, Nora Lia Padola, Paula MA Lucchesi, Marcelo Masana
View Abstract

Escherichia coli Situation in Brazil

- Pp. 162-178 (17)
Beatriz EC Guth, Cyntia F Picheth, Tania AT Gomes
View Abstract

Shiga Toxin Producing Escherichia coli in Chile

- Pp. 179-190 (12)
Roberto M. Vidal, Angel Onate, Juan C. Salazar, Valeria Prado
View Abstract

Epidemiology of Diarrheagenic Escherichia coli Pathotypes in Mexico, Past and Present

- Pp. 191-208 (18)
Armando Navarro, Teresa Estrada-Garcia
View Abstract

Diarrheagenic Escherichia coli in Children from Uruguay, Colombia and Peru

- Pp. 209-222 (14)
Gustavo Varela, Oscar G Gomez-Duarte, Theresa Ochoa
View Abstract

Escherichia coli Animal Reservoirs, Transmission Route and Animal Disease

- Pp. 223-248 (26)
Antonio F Pestana de Castro, Adriana Bentancor, Elsa C Mercado, Angel Cataldi, Alberto E Parma
View Abstract

Host-pathogen Communication

- Pp. 249-255 (7)
Marcelo P Sircili, Cristiano G Moreira, Vanessa Sperandio
View Abstract

Future of Escherichia coli Research in Latin America

- Pp. 256-261 (6)
Tania AT Gomes, Cristina Ibarra, Fernando Navarro-Garcia, Marina Palermo, Valeria Prado, Marta Rivas, Alfredo G Torres
View Abstract

Index

- Pp. 262-264 (3)
Alfredo G. Torres
Download Free

RELATED BOOKS

.An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy.
.COVID-19: Effects in Comorbidities and Special Populations.
.Current Developments in the Detection and Control of Multi Drug Resistance.
.Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences.